Cargando…

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma

BACKGROUND: Mitochondrial ribosomal protein L19 (MRPL19) is a member of the mitochondrial ribosomal protein (MRP) family. MRPs have a role in the progression of many cancers. However, the role of MRPL19 in lung adenocarcinoma (LUAD) is yet unknown. METHODS: The Cancer Genome Atlas (TCGA) and Gene Ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Dong, Sun, Daqiang, Sirera, Rafael, Afzal, Muhammad Zubair, Leong, Tracy L., Li, Xin, Wang, Yuhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413030/ https://www.ncbi.nlm.nih.gov/pubmed/37577299 http://dx.doi.org/10.21037/tlcr-23-306

Ejemplares similares

MRPL42 is activated by YY1 to promote lung adenocarcinoma progression
por: Jiang, Wei, et al.
Publicado: (2021)

MRPL51 is a downstream target of FOXM1 in promoting the malignant behaviors of lung adenocarcinoma
por: Zhang, Wenqian, et al.
Publicado: (2023)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma
por: Zhong, Xugang, et al.
Publicado: (2023)

Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma
por: Li, Dong, et al.
Publicado: (2020)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma
por: Peng, Yunsong, et al.
Publicado: (2022)

Overexpression of P4HA1 associates with poor prognosis and promotes cell proliferation and metastasis of lung adenocarcinoma
por: Ning, Yue, et al.
Publicado: (2021)

IL-8-mediated overexpression of ZNF274 promotes the proliferation and migration of colorectal cancer cells through the transactivation of MRPL40
por: Du, Feng, et al.
Publicado: (2023)

TGFBI Promoter Methylation is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Seok, Yangki, et al.
Publicado: (2019)

MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma
por: Hu, Yangyang, et al.
Publicado: (2023)

Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma
por: Shi, Jie, et al.
Publicado: (2021)

Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma
por: Wang, Xiaoxia, et al.
Publicado: (2018)

Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma
por: Ding, Fang, et al.
Publicado: (2018)

Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma
por: Huang, Xiaoyue, et al.
Publicado: (2022)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

CIP4 Promotes Lung Adenocarcinoma Metastasis and Is Associated with Poor Prognosis
por: Truesdell, P, et al.
Publicado: (2014)

Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2018)

Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion
por: Cai, Songwang, et al.
Publicado: (2015)

Overexpression of TWF1 promotes lung adenocarcinoma progression and is associated with poor prognosis in cancer patients through the MMP1 signaling pathway
por: Zhai, Kui, et al.
Publicado: (2023)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
por: He, Jian, et al.
Publicado: (2023)

[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2023)

Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
por: Zeng, Yangyang, et al.
Publicado: (2021)

Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis
por: Chiou, Jean, et al.
Publicado: (2019)

MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer
por: Jing, Chuanqing, et al.
Publicado: (2021)

The Association between Polymorphisms in the MRPL4 and TNF-α Genes and Susceptibility to Allergic Rhinitis
por: Wei, Xin, et al.
Publicado: (2013)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
por: Wang, Jingshu, et al.
Publicado: (2017)

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
por: Tang, Suping, et al.
Publicado: (2022)

A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity
por: Yeo, Janet H. C., et al.
Publicado: (2015)

Co-overexpression of AXL and c-ABL predicts a poor prognosis in esophageal adenocarcinoma and promotes cancer cell survival
por: Hong, Jun, et al.
Publicado: (2020)

Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma
por: Wang, Jue, et al.
Publicado: (2016)

Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019)

Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma
por: Li, Jiuzhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ama1410humoa7jmos4u8h0ag2b